SEARCH WITHIN CONTENT
VOLUME 2 , ISSUE 5 ( September-October, 2023 ) > List of Articles
Rashmi Joshi, Aravind Sekar, Aman Sharma, Sreedhara B Chaluvashetty, Mini P Singh, Amanjit Bal, Ritambhra Nada
Keywords : Autopsy, Coronavirus disease 2019, Diffuse alveolar damage, Diffuse alveolar hemorrhage, Systemic lupus erythematosus
Citation Information : Joshi R, Sekar A, Sharma A, Chaluvashetty SB, Singh MP, Bal A, Nada R. Double Trouble: Coronavirus Disease 2019 with Lupus Flare. 2023; 2 (5):117-123.
License: CC BY-NC 4.0
Published Online: 27-10-2023
Copyright Statement: Copyright © 2023; The Author(s).
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the coronavirus disease (COVID-19) pandemic, with over 65 million deaths worldwide. Clinical manifestations of COVID-19 varied from asymptomatic to severe acute respiratory distress syndrome. The exact incidence of COVID-19 in lupus patients is not known. However, studies have shown that lupus patients might be more prone to SARS-CoV-2 infection and may have severe clinical manifestations due to aberrant baseline inflammation and dysregulated immune responses. Further, the immunosuppressive treatment that lupus patients receive also compromises their immunity and paves the way for infection. We intend to present the complete clinical and autopsy findings of a 28-year-old female who presented with lupus flares involving major organs and acquired COVID-19 infection during treatment. Subsequently, there was worsening respiratory failure, and she finally succumbed to death despite all supportive measures.